§ 70.54.130. Laetrile -- Legislative declaration
It is the intent of the legislature that passage of RCW 70.54.130 through 70.54.150 shall not constitute any endorsement whatever of the efficacy of amygdalin (Laetrile) in the treatment of cancer, but represents only the legislature's endorsement of a patient's freedom of choice, so long as the patient has been given sufficient information in writing to make an informed decision regarding his/her treatment and the substance is not proven to be directly detrimental to health.
[1977 ex.s. c 122 § 1.]
Sections: Previous 70.54.050 70.54.060 70.54.065 70.54.070 70.54.080 70.54.090 70.54.120 70.54.130 70.54.140 70.54.150 70.54.160 70.54.180 70.54.190 70.54.200 70.54.220 NextLast modified: April 7, 2009